Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opicapone PK/PD in Parkinson's Disease
NCT01568047Phase 2Completed
- Sponsor
- BIAL
- Start
- Feb 2010
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Started Feb 2010; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01568047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568047.